The Making of a COVID-19 Vaccine

The development and production of several life-saving COVID-19 vaccines was a medical miracle, but how did manufacturers manage it? To answer that question, the NAM partnered with Emergent BioSolutions on an exclusive series about the company’s accelerated production efforts—which resulted in drug substance to support hundreds of millions of doses in just a few months.

News

What It Takes to Manufacture a Vaccine

March 25, 2021

You may not know it, but one company has the capacity to manufacture bulk drug substance for more than a billion doses of COVID-19 vaccines annually: Emergent BioSolutions, a global supplier for the Johnson & Johnson vaccine and U.S. supplier…